S22-451 CardioGuardian: A Cell-free RNA Method to Assess Inherited Cardiovascular Disease Risk Stanford scientists have developed CardioGuardian, a method that uses cell-free RNA from a routine blood draw to estimate an individual's inherited risk of cardiovascular disease, capturing heritable risk that conventional DNA-based approaches miss. Michael Binkley Brian Su Ajay Subramanian Ryosuke Kita